Patents expiring in 2031

US 7928057

Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use

Julius-Maximilians-Universitat Wurzburg · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928138

Marine actinomycete taxon for drug and fermentation product discovery

The Regents of the University of California · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928147

Antimicrobial wash and carrier solutions, and uses thereof

Teva Animal Health, Inc. · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928096

Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928194

Recombinant antigen for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928237

Fused ring azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928080

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928213

Nucleic acids encoding chimeric CD154 polypeptides

The Regents of the University of California · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928107

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928129

Nanomolar β-lactamase inhibitors

Northwestern University · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928244

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

Infinity Discovery, Inc. · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7928105

Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones

Takeda Pharmaceutical Company Limited · Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7932074

Multivalent human-bovine rotavirus vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7932052

Use of methanobactin

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7931640

Method for muscle delivery of drugs, nucleic acids and other compounds

Inovio AS · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7931919

Method of producing glycine-stabilized, lyophilized plasma

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7932096

Trioxyethylene gold nanoclusters functionalized with a single DNA

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7932289

Remedy for diabetes

Takeda Pharmaceutical Company Limited · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7932382

Conformationally constrained Smac mimetics and the uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935796

Monoclonal antibodies against ANGPTL3

LEXICON PHARMACEUTICALS, INC. · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935693

Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935351

Use of CPG oligodeoxynucleotides to induce angiogenesis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935721

Spiro-oxindole compounds and their uses as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935357

Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

The Regents of the University of California · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7935714

Compositions for sleeping disorders

Bright Future Pharmaceutical Laboratories · Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939635

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939639

Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939468

Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents

PTC THERAPEUTICS, INC. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939558

Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof

The Regents of the University of California · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939689

Short-acting sedative hypnotic agents for anesthesia and sedation

Theravance, Inc. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939263

Compositions and methods for treating and diagnosing cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939495

Method for improving skin conditions

CAREGEN CO., LTD. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7937889

Green garlic and methods of production

Ophios, LLC · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7939304

Mutant MT-SP1 proteases with altered substrate specificity or activity

Catalyst Biosciences, Inc. · Granted Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943131

Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

GENERAL REGENERATIVES, LTD. · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943770

Fused quinoline derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943593

Compositions comprising inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943148

Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943137

FPRL1 ligands and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943755

Neuron regeneration

Neuregenix Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943626

Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

Takeda Pharmaceutical Company Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943318

Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943332

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

The Board of Regents of the University of Texas System · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943159

Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhibitor (antagonist)

The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943659

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943161

Contrast agent coated medical device

Cook Regentec LLC · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943141

Activated polyoxazolines and compositions comprising the same

Serina Therapeutics, Inc. · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7943775

Small molecules for imaging protein-protein interactions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)